Source disclosure: February 26, 2026, 13:00 JST
KYORIN Pharmaceutical Co.,Ltd. [4569.T]
TOKYO, Feb 26 (Pulse News Wire) -- KYORIN Pharmaceutical Co., Ltd. (4569.T), led by President and CEO Hiroshi Ogihara, announced significant changes to its executive structure and governance framework through a resolution passed during today's board meeting. The company will introduce a delegate-based executive officer system alongside its existing employment-based system as part of efforts to enhance corporate governance and improve the transparency and robustness of its operations.
The new delegate-based executive officer system aims to further separate decision-making and supervisory functions from operational duties, thereby strengthening overall management practices. Under this system, delegate-based executives will be appointed as senior managing directors or higher, while those under the traditional employment model will continue to hold the title of executive director. Additionally, directors will have the ability to concurrently serve as executive officers.
KYORIN plans to implement these changes starting April 1, 2026. In conjunction with the introduction of the new system, several key personnel adjustments were also decided upon. These include maintaining the current roles of Ogihara as both president and CEO, Masayuki Kurose as CFO and Chief Strategy Officer, and Michiyasu Tajima as Chief Business Development Officer and Chief Commercial Officer.
Other notable promotions within the new delegate-based executive ranks include Toshio Yamamura, who will transition from an executive director to a senior managing director overseeing IT solutions and diagnostic business units, Shunichi Ishiyama moving up to become a senior managing director responsible for drug development and intellectual property departments, and Ken'ya Jyouda being promoted to an executive director role focusing on pharmaceutical innovation advancement after previously serving as product strategy department head.
Furthermore, the company has made additional appointments including Hiroki Usui, who will take over as the head of the reliability assurance division, and Koji Matsuoka, who will assume the position of chief human resources officer and oversee general affairs and compliance divisions.
These organizational shifts reflect KYORIN’s commitment to enhancing its corporate governance structures and aligning its leadership team more closely with strategic objectives aimed at driving future growth and sustainability.
The company disclosed details regarding changes to its board and executive management. For full details, please refer to the original disclosure document.
AI-translated content. 🟡 Confidence: Standard See terms • Original filing